📰 Acelyrin News
Page 4 - Acelyrin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Acelyrin. Real-time updates on events, politics, business and more.
December 2, 2023
Acelyrin (NASDAQ:SLRN – Free Report) had its price objective reduced by Morgan Stanley from $19.00 to $13.00 in a research note published on Wednesday morning, Benzinga reports. They currently have an equal weight rating on the stock. Several other analysts also recently weighed in on SLRN. Jefferies Financial Group reduced their price objective on shares […]
December 2, 2023
HC Wainwright restated their buy rating on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $30.00 price objective on the stock. Separately, Morgan Stanley lowered Acelyrin from an overweight rating to an equal weight rating and lowered their price […]
November 29, 2023
By Chris Wack Fortrea said in a filing to the U.S. Securities and Exchange Commission that it disputes the accuracy of statements made by Acelyrin regarding...
November 29, 2023
HC Wainwright reaffirmed their buy rating on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. Separately, Morgan Stanley cut Acelyrin from an overweight rating to an equal weight rating and dropped their target price […]
November 28, 2023
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC....
November 28, 2023
Zscaler shares fall after the cybersecurity company's fiscal-year forecast for calculated billings disappoints, and Boeing stock is upgraded. CrowdStrike,...
November 27, 2023
By Ben Glickman Shares of Acelyrin fell on Monday after the company said there was a programming error in its drug trial of a treatment for psoriatic...
November 27, 2023
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the...
November 27, 2023
By Sabela Ojea iBio on Monday announced a 20-to-1 reverse stock split. Shares of the biopharmaceutical company declined 8.6% to 26 cents in after-hours...
November 26, 2023
NEW YORK, Nov. 25, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that...